Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justus C Dächsel

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Archives of Neurology|May 12, 2010
LRRK2 and Parkinson diseaseJustus C Dächsel, Matthew J Farrer
The FEBS Journal|December 25, 2010
P25α / TPPP expression increases plasma membrane presentation of the dopamine transporter and enhances cellular sensitivity to dopamine toxicityAnja W Fjorback, Sabrina Sundbye, Justus C Dächsel, et al.
Parkinsonism & Related Disorders|September 21, 2010
A comparative study of Lrrk2 function in primary neuronal culturesJustus C Dächsel, Bahareh Behrouz, Mei Yue, et al.
Parkinsonism & Related Disorders|July 1, 2008
Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cellsAndreas Koch, Klaus Lehmann-Horn, Justus C Dächsel, et al.
Scientific Reports|September 2, 2017
Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cellsKenneth Thirstrup, Justus C Dächsel, Felix S Oppermann, et al.
Parkinsonism & Related Disorders|January 16, 2007
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in AsiaMatthew J Farrer, Jeremy T Stone, Chin-Hsien Lin, et al.
Acta Neuropathologica|December 8, 2006
Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusionsJustus C Dächsel, Owen A Ross, Ignacio F Mata, et al.
Neuroscience Letters|November 11, 2006
Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2Justus C Dächsel, Ignacio F Mata, Owen A Ross, et al.
Parkinsonism & Related Disorders|April 3, 2007
Identification of potential protein interactors of Lrrk2Justus C Dächsel, Julie P Taylor, Su San Mok, et al.
Molecular Neurodegeneration|June 1, 2012
LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviorsKelly M Hinkle, Mei Yue, Bahareh Behrouz, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Archives of Neurology|May 12, 2010
LRRK2 and Parkinson diseaseJustus C Dächsel, Matthew J Farrer
The FEBS Journal|December 25, 2010
P25α / TPPP expression increases plasma membrane presentation of the dopamine transporter and enhances cellular sensitivity to dopamine toxicityAnja W Fjorback, Sabrina Sundbye, Justus C Dächsel, et al.
Parkinsonism & Related Disorders|September 21, 2010
A comparative study of Lrrk2 function in primary neuronal culturesJustus C Dächsel, Bahareh Behrouz, Mei Yue, et al.
Parkinsonism & Related Disorders|July 1, 2008
Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cellsAndreas Koch, Klaus Lehmann-Horn, Justus C Dächsel, et al.
Scientific Reports|September 2, 2017
Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cellsKenneth Thirstrup, Justus C Dächsel, Felix S Oppermann, et al.
Parkinsonism & Related Disorders|January 16, 2007
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in AsiaMatthew J Farrer, Jeremy T Stone, Chin-Hsien Lin, et al.
Acta Neuropathologica|December 8, 2006
Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusionsJustus C Dächsel, Owen A Ross, Ignacio F Mata, et al.
Neuroscience Letters|November 11, 2006
Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2Justus C Dächsel, Ignacio F Mata, Owen A Ross, et al.
Parkinsonism & Related Disorders|April 3, 2007
Identification of potential protein interactors of Lrrk2Justus C Dächsel, Julie P Taylor, Su San Mok, et al.
Molecular Neurodegeneration|June 1, 2012
LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviorsKelly M Hinkle, Mei Yue, Bahareh Behrouz, et al.
Pageof 2